|
Chain Drug Review
Click on article title to view & purchase. Articles are sorted by their publication date in reverse chronological order.
Total result: 89 articles |
Page 1 of 2
|
Drug chains in enviable position in O-T-Cs. June 21, 2004
Chain drug stocks continue rebound. June 21, 2004
An entrepreneurial spirit reigns. June 21, 2004
MSI offers insights into Rx practice. June 21, 2004
Vigilance against counterfeit drugs a priority. June 21, 2004
Wrigley flexes muscle in children's arena. June 21, 2004
CDMA harnesses buying power of 8,000 stores. June 21, 2004
Puig builds portfolio with four major launches. June 21, 2004
Active solves dilemma of excess inventory. June 21, 2004
Zooth is in forefront of 'retro' license trend. June 21, 2004
Pharmacy is part of the community. June 21, 2004
Shoppers want choice; retailers give it to them. June 21, 2004
Pharmacies try to help seniors through maze. June 21, 2004
New front in Medicaid rate battle. June 21, 2004
Supermarketers have their own special headaches. June 21, 2004
Advanced Medical Optics aims to raise profile. June 21, 2004
Ansell touts high-quality products, services. June 21, 2004
RFID and the pharmaceutical supply chain. June 21, 2004
Stratmar makes 'retailtainment' its speciality. June 21, 2004
Western Research 'shakes up' laxative category. June 21, 2004
Carbolite fosters growth of low-carb lifestyle. June 21, 2004
Maybelline breakthroughs come fast, furious. June 21, 2004
Dialogue. June 21, 2004
Paul Murphy, executive vice president, Revlon Inc. June 21, 2004
Checkpoint on cutting edge of retail technology. June 21, 2004
E.T. Browne builds on heritage in skin, hair care. June 21, 2004
Woodward products make skin, nails healthier. June 21, 2004
Neutrogena builds on tradition of innovation. June 21, 2004
Elizabeth Arden ups support for drug channel. June 21, 2004
McNeil's Splenda 'a phenomenal growth engine'. June 21, 2004
Similasan market strategy avoids me-too status. June 21, 2004
Merix focuses on building RELEEV brand. June 21, 2004
Smart Brands 'fills need, generates excitement'. June 21, 2004
PTS Labs serves the best interest of children. June 21, 2004
Health Products a force in branded, PL fields. June 21, 2004
Church & Dwight builds robust brand portfolio. June 21, 2004
Hyland's offers 'natural remedies that work'. June 21, 2004
L'eggs products offer new benefits, solutions. June 21, 2004
Anda bridges gap between suppliers, retailers. June 21, 2004
Unilever demonstrates that less can be more. June 21, 2004
Continental extends reach into men's hair care. June 21, 2004
Boots brings skin care lines to U.S. market. June 21, 2004
Retailers react to the changing face of beauty. June 21, 2004
Glamour lets readers judge best new H&BAs. June 21, 2004
Sophisticated data gives insights into what's shaping the H&BA market. June 21, 2004
Ideavillage a power in 'as seen on TV' category. June 21, 2004
CVS is ready to put stamp on California. June 21, 2004
Longs settles lawsuit; profits to be impacted. June 21, 2004
Ex-Rite Aid exec gets probation, not prison. June 21, 2004
Kids Care line 'safe, efficacious, functional'. June 21, 2004
Beauty Beat markets line 'that really works'. June 21, 2004
New owner out to change perception of Jane. June 21, 2004
At AquaCell it's about much more than water. June 21, 2004
With 30 years of experience, Windmill delivers. June 21, 2004
Consumer-mandated innovation fuels Novartis. June 21, 2004
Improved service, new products enable Clay-Park to triple sales. June 07, 2004
Generic access. June 07, 2004
Drugs not always first choice. June 07, 2004
As category's scope grows, so does opportunity. June 07, 2004
Teens with diabetes learn to 'Dream Big'. June 07, 2004
Targeted marketing now a must. June 07, 2004
PL items can raise margins. June 07, 2004
Mylan posts record sales and earnings. June 07, 2004
Generics use yields savings in Michigan. June 07, 2004
Andrx to sell Genpharm's version of Paxil. June 07, 2004
FluMist repurchase O.K.'d. June 07, 2004
Senate lauded for passage of project BioShield Act. June 07, 2004
D-T-C ad changes sought. June 07, 2004
Canada proposes "morning after" access. June 07, 2004
FDA reiterates curbs on ties with industry. June 07, 2004
Senate GOP proposes health plan. June 07, 2004
N.J. focuses on drugmakers. June 07, 2004
Psychologists given prescription authority. June 07, 2004
Pfizer settles marketing case. June 07, 2004
Propulsid award vacated. June 07, 2004
More
articles from Chain Drug Review...
|